“When You're Getting High… You Just Don't Want to Be Around Anybody.” A Qualitative Exploration of Reasons for Injecting Alone: Perspectives from Young People Who Inject Drugs

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®) (5th ed.). American Psychiatric Pub.
   Google Scholar
• Baltimore City Health Department. (2018). Baltimore City’s response to the opioid epidemic. https://health.baltimorecity.gov/opioid-overdose/baltimore-city-overdose-prevention-and-response-information.
   Google Scholar
• Banta-Green, C., Kuszler, P., Coffin, P., & Schoeppe, J. (2011). Washington’s 911 Good Samaritan drug overdose law-initial evaluation results. Alcohol & Drug Abuse Institute.
   Google Scholar
• Bardwell, G., Kerr, T., Boyd, J., & McNeil, R. (2018). Characterizing peer roles in an overdose crisis: Preferences for peer workers in overdose response programs in emergency shelters. Drug and Alcohol Dependence, 190, 6–8. https://doi.org/10.1016/j.drugalcdep.2018.05.023
   PubMed Web of Science ®Google Scholar
• Bardwell, G., Kerr, T., & McNeil, R. (2019). The opioid overdose epidemic and the urgent need for effective public health interventions that address men who use drugs alone. American Journal of Men's Health, 13(3), 1557988319859113. https://doi.org/10.1177/1557988319859113
   Web of Science ®Google Scholar
• Bennett, T., & Holloway, K. (2012). The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: An evaluation of the THN project in Wales. Drugs: Education, Prevention and Policy, 19(4), 320–328. https://doi.org/10.3109/09687637.2012.658104
   Web of Science ®Google Scholar
• BMORE POWER. (2019). Go slow fentanyl is here: Harm reduction tips. http://www.20secondssaves.org/
   Google Scholar
• British Columbia Centre for Disease Control. (2015). Fentanyl campaign launches to raise awareness about the dangers of the drug. http://www.bccdc.ca/about/news-stories/news-releases/2015/fentanyl-campaign-launches-to-raise-awareness-about-the-dangers-of-the-drug
   Google Scholar
• Carey, J. W., Morgan, M., & Oxtoby, M. J. (1996). Intercoder agreement in analysis of responses to open-ended interview questions: Examples from tuberculosis research. CAM Journal, 8(3), 1–5. https://doi.org/10.1177/1525822X960080030101
   Google Scholar
• Carroll, J. J., Marshall, B. D., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. International Journal of Drug Policy, 46, 136–145. https://doi.org/10.1016/j.drugpo.2017.05.023
   PubMed Web of Science ®Google Scholar
• Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine, 8(3), 153–163.
   PubMed Web of Science ®Google Scholar
• Connors, M. M. (1994). Stories of pain and the problem of AIDS prevention: Injection drug withdrawal and its effect on risk behavior. Medical Anthropology Quarterly, 8(1), 47–68. https://doi.org/10.1525/maq.1994.8.1.02a00040
   Web of Science ®Google Scholar
• Cooper, H., Friedman, S. R., Tempalski, B., Friedman, R., & Keem, M. (2005). Racial/ethnic disparities in injection drug use in large US metropolitan areas. Annals of Epidemiology, 15(5), 326–334. https://doi.org/10.1016/j.annepidem.2004.10.008
   PubMed Web of Science ®Google Scholar
• Desmon, S. (2018). Go slow: Using harm-reduction messages to save lives in Baltimore. https://ccp.jhu.edu/2018/07/30/reducing-overdose-deaths-baltimore/
   Google Scholar
• Doherty, M. C., Garfein, R. S., Monterroso, E., Latkin, C., & Vlahov, D. (2000). Gender differences in the initiation of injection drug use among young adults. Journal of Urban Health, 77(3), 396–414. https://doi.org/10.1007/BF02386749
   PubMed Web of Science ®Google Scholar
• Forseth, K. (2016). Fentanyl and overdose: Harm reduction strategies. https://bha.health.maryland.gov/NALOXONE/Documents/BHA%20Webinar%20Fentanyl%20and%20Overdose%20Harm%20Reduction%20Strategies%2012.20.16%20(1).pdf
   Google Scholar
• Frank, D., Mateu-Gelabert, P., Guarino, H., Bennett, A., Wendel, T., Jessell, L., & Teper, A. (2015). High risk and little knowledge: Overdose experiences and knowledge among young adult nonmedical prescription opioid users. The International Journal on Drug Policy, 26(1), 84–91. https://doi.org/10.1016/j.drugpo.2014.07.013
   PubMed Web of Science ®Google Scholar
• Gladden, R. M. (2016). Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths—27 states, 2013–2014. MMWR.Morbidity and Mortality Weekly Report, 65(33), 837–843.
   Web of Science ®Google Scholar
• Hagan, H., Campbell, J. V., Thiede, H., Strathdee, S. A., Ouellet, L., Latka, M., Hudson, S., & Garfein, R. S. (2007). Injecting alone among young adult IDUs in five US cities: Evidence of low rates of injection risk behavior. Drug and Alcohol Dependence, 91, S48–S55. https://doi.org/10.1016/j.drugalcdep.2007.02.002
   PubMed Web of Science ®Google Scholar
• Harm Reduction Coalition. (2018). Tolerance: Prevention tips. https://harmreduction.org/issues/overdose-prevention/overview/overdose-basics/opioid-od-risks-prevention/tolerance/
   Google Scholar
• Health Resource Center-Baltimore Health. (2016). Staying alive drug overdose prevention and response program. https://www.baltimorehealth.org/stayingalive/
   Google Scholar
• Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017). Public health and public order outcomes associated with supervised drug consumption facilities: A systematic review. Current HIV/AIDS Reports, 14(5), 161–183. https://doi.org/10.1007/s11904-017-0363-y
   PubMed Web of Science ®Google Scholar
• Kerr, T., Small, W., Hyshka, E., Maher, L., & Shannon, K. (2013). It's more about the heroin’: Injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction, 108(7), 1270–1276. https://doi.org/10.1111/add.12151
   PubMed Web of Science ®Google Scholar
• Krieger, M. S., Goedel, W. C., Buxton, J. A., Lysyshyn, M., Bernstein, E., Sherman, S. G., Rich, J. D., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018). Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy, 61, 52–58. https://doi.org/10.1016/j.drugpo.2018.09.009
   PubMed Web of Science ®Google Scholar
• Latkin, C. A., Sherman, S., & Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22(4), 332–339. https://doi.org/10.1037/0278-6133.22.4.332
   PubMed Web of Science ®Google Scholar
• Marshall, B. D., Milloy, M. J., Wood, E., Montaner, J. S., & Kerr, T. (2011). Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet, 377(9775), 1429–1437. https://doi.org/10.1016/S0140-6736(10)62353-7
   PubMed Web of Science ®Google Scholar
• Maryland Department of Health and Mental Hygiene. (2016). Good Samaritan law fact sheet. Behavioral Health Administration.
   Google Scholar
• Maryland Department of Health and Mental Hygiene. (2017). Drug- and alcohol-related intoxication deaths in Maryland, 2016. https://bha.health.maryland.gov/OVERDOSE_PREVENTION/Documents/Maryland%202016%20Overdose%20Annual%20report.pdf
   Google Scholar
• Maryland Department of Health Behavioral Health Administration. (2018). Good Samaritan Law. https://bha.health.maryland.gov/overdose_prevention/pages/good-samaritan-law.aspx
   Google Scholar
• Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S. R. (2010). Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks. The International Journal on Drug Policy, 21(3), 179–185. https://doi.org/10.1016/j.drugpo.2009.08.007
   PubMed Web of Science ®Google Scholar
• McDonald, R., & Strang, J. (2016). Are take‐home naloxone programmes effective? systematic review utilizing application of the bradford hill criteria. Addiction, 111(7), 1177–1187. https://doi.org/10.1111/add.13326
   PubMed Web of Science ®Google Scholar
• McGinty, E. E., Barry, C. L., Stone, E. M., Niederdeppe, J., Kennedy-Hendricks, A., Linden, S., & Sherman, S. G. (2018). Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Preventive Medicine, 111, 73–77. https://doi.org/10.1016/j.ypmed.2018.02.026
   PubMed Web of Science ®Google Scholar
• Metsch, L. R., McCOY, C. B., Shultz, J. M., Page, J. B., Philippe, E., & McKAY, C. (1999). Gender comparisons of injection drug use practices in shooting galleries. Population Research and Policy Review, 18(1/2), 101–117. https://doi.org/10.1023/A:1006109028818
   Web of Science ®Google Scholar
• Mihailovic, A., Tobin, K., & Latkin, C. (2015). The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland. AIDS and Behavior, 19(10), 1792–1800. https://doi.org/10.1007/s10461-015-1048-4
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. (2019). Overdose death rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
   Google Scholar
• National Institute on Drug Abuse. (2020). Substance use in women: Sex and gender difference in substance use. https://www.drugabuse.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use
   Google Scholar
• O'Donnell, J. K., Gladden, R. M., & Seth, P. (2017). Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region - United States, 2006-2015. MMWR. Morbidity and Mortality Weekly Report, 66(34), 897–903. https://doi.org/10.15585/mmwr.mm6634a2
   PubMed Web of Science ®Google Scholar
• O'Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017). Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016. MMWR. Morbidity and Mortality Weekly Report, 66(43), 1197–1202. https://doi.org/10.15585/mmwr.mm6643e1
   PubMed Web of Science ®Google Scholar
• Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the southeastern United States. The International Journal on Drug Policy, 63, 122–128. https://doi.org/10.1016/j.drugpo.2018.08.007
   PubMed Web of Science ®Google Scholar
• Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017). Misuse of novel synthetic opioids: A deadly new trend. Journal of Addiction Medicine, 11(4), 256–265. https://doi.org/10.1097/ADM.0000000000000324
   PubMed Web of Science ®Google Scholar
• Prescription Drug Abuse Policy Systems. (2019). Drug Induced Homicide Laws. http://www.pdaps.org/datasets/drug-induced-homicide-1529945480-1549313265-1559075032
   Google Scholar
• Ries, R. K., Miller, S. C., & Fiellin, D. A. (2009). Principles of addiction medicine. Lippincott Williams & Wilkins.
   Google Scholar
• Ross, M. W., Wodak, A., Stowe, A., & Gold, J. (1994). Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction (Abingdon, England), 89(4), 473–479. https://doi.org/10.1111/j.1360-0443.1994.tb00928.x
   PubMed Web of Science ®Google Scholar
• Seth, P., Rudd, R. A., Noonan, R. K., & Haegerich, T. M. (2018). Quantifying the Epidemic of Prescription Opioid Overdose Deaths. American Journal of Public Health, 108(4), 500–502.
   PubMed Web of Science ®Google Scholar
• Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018). Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR. Morbidity and Mortality Weekly Report, 67(12), 349–358. https://doi.org/10.15585/mmwr.mm6712a1
   PubMed Web of Science ®Google Scholar
• Sherman, S. G., Fuller, C. M., Shah, N., Ompad, D. V., Vlahov, D., & Strathdee, S. A. (2005). Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: The need for early intervention. Journal of Psychoactive Drugs, 37(4), 437–443. https://doi.org/10.1080/02791072.2005.10399817
   PubMed Web of Science ®Google Scholar
• Stein, M. D., Dubyak, P., Herman, D., & Anderson, B. J. (2007). Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative. The American Journal of Drug and Alcohol Abuse, 33(4), 517–525. https://doi.org/10.1080/00952990701407298
   PubMed Web of Science ®Google Scholar
• Strauss, A., & Corbin, J. M. (1997). Grounded theory in practice. Sage.
   Google Scholar
• The Harm Reduction Coalition. (2017). Principles of harm reduction. https://harmreduction.org/about-us/principles-of-harm-reduction/
   Google Scholar
• Tobin, K. E., Kuramoto, S. J., Davey‐Rothwell, M. A., & Latkin, C. A. (2011). The STEP into action study: A peer‐based, personal risk network‐focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction (Abingdon, England), 106(2), 366–375. https://doi.org/10.1111/j.1360-0443.2010.03146.x
   PubMed Web of Science ®Google Scholar
• Unger, L. (2019, August). “Go slow” – Baltimore's peer-led fentanyl harm reduction campaign. https://filtermag.org/go-slow-fentanyl-harm-reduction/
   Google Scholar
• VERBI GmbH. (2019). MAXQDA: Professional software for qualitative & mixed methods research. https://www.maxqda.com/
   Google Scholar
• Wang, S. (2019). Historical review: Opiate addiction and opioid receptors. Cell Transplantation, 28(3), 233–238.
   PubMed Web of Science ®Google Scholar